Advertisement

Ads Placeholder
Loading...

3SBio Inc.

TRSBFPNK
Healthcare
Biotechnology
$3.00
$0.00(0.00%)
U.S. Market opens in 4h 53m

3SBio Inc. Fundamental Analysis

3SBio Inc. (TRSBF) shows strong financial fundamentals with a PE ratio of 5.94, profit margin of 47.86%, and ROE of 38.42%. The company generates $17.0B in annual revenue with strong year-over-year growth of 16.53%.

Key Strengths

ROE38.42%
Operating Margin59.56%
Cash Position271.41%
PEG Ratio0.00
Current Ratio5.13

Areas of Concern

No major concerns flagged.
We analyze TRSBF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 81.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
81.4/100

We analyze TRSBF's fundamental strength across five key dimensions:

Efficiency Score

Excellent

TRSBF demonstrates superior asset utilization.

ROA > 10%
23.06%

Valuation Score

Excellent

TRSBF trades at attractive valuation levels.

PE < 25
5.94
PEG Ratio < 2
0.00

Growth Score

Excellent

TRSBF delivers strong and consistent growth momentum.

Revenue Growth > 5%
16.53%
EPS Growth > 10%
40.98%

Financial Health Score

Excellent

TRSBF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.10
Current Ratio > 1
5.13

Profitability Score

Excellent

TRSBF achieves industry-leading margins.

ROE > 15%
38.42%
Net Margin ≥ 15%
47.86%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRSBF Expensive or Cheap?

P/E Ratio

TRSBF trades at 5.94 times earnings. This suggests potential undervaluation.

5.94

PEG Ratio

When adjusting for growth, TRSBF's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values 3SBio Inc. at 1.82 times its book value. This may indicate undervaluation.

1.82

EV/EBITDA

Enterprise value stands at 5.34 times EBITDA. This is generally considered low.

5.34

How Well Does TRSBF Make Money?

Net Profit Margin

For every $100 in sales, 3SBio Inc. keeps $47.86 as profit after all expenses.

47.86%

Operating Margin

Core operations generate 59.56 in profit for every $100 in revenue, before interest and taxes.

59.56%

ROE

Management delivers $38.42 in profit for every $100 of shareholder equity.

38.42%

ROA

3SBio Inc. generates $23.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

23.06%

Following the Money - Real Cash Generation

Operating Cash Flow

3SBio Inc. produces operating cash flow of $2.05B, showing steady but balanced cash generation.

$2.05B

Free Cash Flow

3SBio Inc. produces free cash flow of $1.35B, offering steady but limited capital for shareholder returns and expansion.

$1.35B

FCF Per Share

Each share generates $0.57 in free cash annually.

$0.57

FCF Yield

TRSBF converts 2.87% of its market value into free cash.

2.87%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

5.94

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.003

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.82

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.77

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.13

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.38

vs 25 benchmark

ROA

Return on assets percentage

0.23

vs 25 benchmark

ROCE

Return on capital employed

0.33

vs 25 benchmark

How TRSBF Stacks Against Its Sector Peers

MetricTRSBF ValueSector AveragePerformance
P/E Ratio5.9428.23 Better (Cheaper)
ROE38.42%737.00% Weak
Net Margin47.86%-46175.00% (disorted) Strong
Debt/Equity0.100.35 Strong (Low Leverage)
Current Ratio5.134.10 Strong Liquidity
ROA23.06%-17785.00% (disorted) Strong

TRSBF outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 3SBio Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

76.57%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

121.33%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

74.87%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ